Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Huangbai Liquid for diabetic foot wounds
ChiCTR-IPR-15007182Phase 4Not yet recruiting
- Sponsor
- Zhu Xianyi Memorial Hospital
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of compound phellodendron liquid in diabetic foot ulcer (DFU), diabetic foot infection (DFI) and diabetic foot osteomyelitis (DFO) (2 arms), sponsored by Zhu Xianyi Memorial Hospital. Primary endpoints: Healing area, Bacterial and 3 more. Planned start Oct 2015; status: not yet recruiting.
02
Drugs
compound phellodendron liquid
03
Conditions
diabetic foot ulcer (DFU)diabetic foot infection (DFI)diabetic foot osteomyelitis (DFO)
Beyond the preview
Go deeper on ChiCTR-IPR-15007182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15007182.